ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joyce Barlin, MD
GOG Partners
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Treatment Centers of America, Phoenix. 403
Goodyear, Arizona, United States
- Honor Health, Usor, 406
Phoenix, Arizona, United States
- Nuvance Health System, 401
Danbury, Connecticut, United States
- Baptist Md Anderson Cancer Center, 404
Jacksonville, Florida, United States
- Sudarshan Sharma, Md. Ltd. 414
Hinsdale, Illinois, United States
- Cancer Treatment Centers of America, Chicago. 410
Zion, Illinois, United States
- Northwest Cancer Centers - Dyer, in - Usor, 422
Dyer, Indiana, United States
- Baptist Health Lexington, 407
Lexington, Kentucky, United States
- Norton Cancer Institute - St. Matthews, 416
Louisville, Kentucky, United States
- Willis-Knighton Physician Network / Gynecologic Oncology Associates, 409
Shreveport, Louisiana, United States
- Minnesota Oncology Hematology, P. A. - Usor, 421
Maplewood, Minnesota, United States
- Center of Hope, 413
Reno, Nevada, United States
- the Valley Hosptial, Inc. 411
Ridgewood, New Jersey, United States
- Women'S Cancer Care Associates, Llc. 405
Albany, New York, United States
- the Ohio State University James Cancer Center, 412
Columbus, Ohio, United States
- Oncology Associates of Oregon, P. C. - Usor. 419
Eugene, Oregon, United States
- Texas Oncology, P. A. - Austin, Usor. 417
Austin, Texas, United States
- Texas Oncology, P.A., Fort Worth - Usor. 420
Fort Worth, Texas, United States
- Texas Oncology, P. A. Woodlands - Usor, 418
The Woodlands, Texas, United States
- Texas Oncology - Northeast Texas - Usor, 423
Tyler, Texas, United States
- Medical College of Wisconsin, 408
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Dec 2022
- Primary completion
- 30 Aug 2026
- Completion
- 30 Aug 2026
- Last update posted
- 13 Apr 2026
- Registered enrollment
- 58
- Registry id
- NCT05446298
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.